DK427989A - Anvendelse af transgluataminaser som immunosuppresiva - Google Patents

Anvendelse af transgluataminaser som immunosuppresiva

Info

Publication number
DK427989A
DK427989A DK427989A DK427989A DK427989A DK 427989 A DK427989 A DK 427989A DK 427989 A DK427989 A DK 427989A DK 427989 A DK427989 A DK 427989A DK 427989 A DK427989 A DK 427989A
Authority
DK
Denmark
Prior art keywords
transgluataminas
immunosuppresiva
transglutaminases
transglutaminase
preparing
Prior art date
Application number
DK427989A
Other languages
English (en)
Other versions
DK427989D0 (da
DK174512B1 (da
Inventor
Thomas Stief
Norbert Heimburger
Hans Ulrich Schorlemmer
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK427989D0 publication Critical patent/DK427989D0/da
Publication of DK427989A publication Critical patent/DK427989A/da
Application granted granted Critical
Publication of DK174512B1 publication Critical patent/DK174512B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK198904279A 1988-08-31 1989-08-30 Anvendelse af transgluataminaser som immunosuppresiva samt præparater indeholdende en transglutaminase og en plasminogen-aktivator-inhibitor DK174512B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3829524 1988-08-31
DE3829524A DE3829524A1 (de) 1988-08-31 1988-08-31 Verwendung von transglutaminasen als immunsuppressiva

Publications (3)

Publication Number Publication Date
DK427989D0 DK427989D0 (da) 1989-08-30
DK427989A true DK427989A (da) 1990-03-01
DK174512B1 DK174512B1 (da) 2003-05-05

Family

ID=6361974

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198904279A DK174512B1 (da) 1988-08-31 1989-08-30 Anvendelse af transgluataminaser som immunosuppresiva samt præparater indeholdende en transglutaminase og en plasminogen-aktivator-inhibitor

Country Status (11)

Country Link
US (2) US5464615A (da)
EP (1) EP0358995B1 (da)
JP (1) JP2831045B2 (da)
KR (1) KR0154523B1 (da)
AT (1) ATE94762T1 (da)
AU (1) AU627489B2 (da)
CA (1) CA1338776C (da)
DE (2) DE3829524A1 (da)
DK (1) DK174512B1 (da)
ES (1) ES2059658T3 (da)
PT (1) PT91583B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3829523A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von plasminogen-aktivator-inhibitor (pai-2) zur immunsuppression
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva
JPH03240738A (ja) * 1990-02-20 1991-10-28 Hoechst Japan Ltd 糖尿病性壊疽治療剤
WO1993020837A1 (fr) * 1992-04-21 1993-10-28 Ajinomoto Co., Inc. Remede contre les plaies
DK0669834T3 (da) * 1992-11-12 2000-04-17 Zymogenetics Inc Anvendelse af topisk påført faktor Xlll til inhibering af blødning
AU674061B2 (en) * 1993-03-30 1996-12-05 Hoechst Japan Limited Factor XIII for treatment of skin wounds
DE19630557C2 (de) * 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
WO1998051333A1 (en) * 1997-05-14 1998-11-19 Zymogenetics, Inc. Use of factor xiii for the manufacture of a medicament for the treatment of reperfusion injury and mucosal damage
EP1201136A1 (en) * 2000-10-31 2002-05-02 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Food grade transglutaminase inhibitor and uses thereof
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2017009136A1 (en) 2015-07-15 2017-01-19 Novo Nordisk Health Care Ag Factor xiii for the treatment of interstitial cystitis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3360633D1 (en) * 1982-02-12 1985-10-03 Unitika Ltd Anti-cancer device
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
DE3850683T2 (de) * 1987-02-09 1994-10-27 Lubrizol Genetics Inc Hybrides RNS-Virus.
JPS63196520A (ja) * 1987-02-09 1988-08-15 Hoechst Japan Kk 潰瘍性大腸炎治療剤
US5013719A (en) * 1988-05-13 1991-05-07 Merrell Dow Pharmaceuticals Inc. Method of effecting immunosuppression
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
EP0358995A2 (de) 1990-03-21
AU4090489A (en) 1990-03-08
DK427989D0 (da) 1989-08-30
ATE94762T1 (de) 1993-10-15
DK174512B1 (da) 2003-05-05
US5464615A (en) 1995-11-07
PT91583B (pt) 1995-05-31
KR900002802A (ko) 1990-03-23
US5695753A (en) 1997-12-09
PT91583A (pt) 1990-03-30
KR0154523B1 (ko) 1998-11-16
DE58905671D1 (de) 1993-10-28
DE3829524A1 (de) 1990-03-01
AU627489B2 (en) 1992-08-27
JP2831045B2 (ja) 1998-12-02
EP0358995A3 (en) 1990-08-16
ES2059658T3 (es) 1994-11-16
CA1338776C (en) 1996-12-10
JPH02108631A (ja) 1990-04-20
EP0358995B1 (de) 1993-09-22

Similar Documents

Publication Publication Date Title
DK427989A (da) Anvendelse af transgluataminaser som immunosuppresiva
DK463989A (da) Farmaceutisk virksom kombination
DE69132006D1 (de) Thiazolederivate als inhibitoren von aktivem sauerstoff
ES531633A0 (es) Un procedimiento para la preparacion de una composicion liquida que contiene un generador se poroxiacido y peroxido de hidrogeno o un adicto del mismo.
DE69128034D1 (de) Enzymatische änderung des haarwuchses
KR950702959A (ko) 레트로바이러스 프로테아제 저해제로서 유용한 n--술폰아미드(n-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retorviral protease inhibitors)
ES2101578T3 (es) Agente analgesico y su utilizacion.
FI906008A0 (fi) Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi
DK0506791T3 (da) Enzymholdigt præparat og detergent indeholdende et sådant præparat
ES2044840T3 (es) Composiciones estabilizadas del activador del plasminogeno de tejido humano.
DK8091A (da) Kontrastmidler indeholdende stabile friradikaler
DE3680271D1 (de) Thrombolytische zusammensetzung und verfahren zu deren herstellung.
FI955721A7 (fi) Urokinaasityyppisen plasminogeenin aktivaattorin inhibiittoreiden ilme ntämiseksi
IL91131A (en) Method of preserving ophthalmic solutions using a hydrogen peroxide source and compositions therefor
DE58906241D1 (de) Verwendung von Plasminogen-Aktivator-Inhibitor (PAI-2) zur Immunsuppression.
DK425586D0 (da) Fremgangsmaade til bestemmelse af proteaseinhibitorer
ES2038127T3 (es) Procedimiento para preparar monosulfactamas.
FR2635008B1 (fr) Agent activateur de la productivite specifique des cellules animales recombinantes a base de polyvinylpyrrolidone et milieu de culture defini le contenant
DK19489D0 (da) Fremgangsmaade til stabilisering af cephalosporinderivater samt stabile praeparater med cephalosporinderivater
GR3020389T3 (en) Calibrator and use thereof in an immuno-assay
TR199700409T1 (xx) Harici kullan�ma mahsus enflamasyon �nleyici madde.
WO1992020059A3 (en) Demonstration control system (dcs)
DE59008693D1 (de) Gewebs-Plasminogen-Aktivator-Derivat.
DK321789A (da) Anvendelse af ajoen og ajoenderivater som eller i cytostatika og/eller cytotoksika samt middel indeholdende disse forbindelser
ES2070881T3 (es) Ensayo global para determinar los componentes principales del sistema fibrinolitico.

Legal Events

Date Code Title Description
PUP Patent expired